After controlling for other covariates, increased risk for CA-CDI was associated with use of beta-lactam/beta-lactamase inhibitors, cephalosporins, clindamycin, fluoroquinolones, macrolides, and penicillins (Table 3). The gene discussed is LACTB; the disease is clostridium difficile infection.